FDA.reportPublic FDA data

Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection

RxCUI
1119989
RxNorm name
Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection
Display name
Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection
Full name
Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125335AnascorpCentruroides (Scorpion) Immune F(ab')2 (Equine) Injection351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5cb65048-a30c-48e5-8bc8-897983d08068Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection [PSN] · Centruroides (scorpion) immune F(ab')2 (equine) 120 MG Injection [SCD]220These highlights do not include all the information needed to use ANASCORP safely and effectively. See full prescribing information for ANASCORP. ANASCORP® centruroides (scorpion) immune F(ab') 2 (equine) injection Lyophilized for Solution For Intravenous Use Only Initial U.S. Approval: 201120250716